Want to join the conversation?
Biopharmaceutical company $ICPT reported 3Q15 net loss of $50.9MM or $2.10 per share compared to a loss of $35.8MM or $1.69 per share in 3Q14. The net loss increase was primarily the result of increases in G&A expenses related to $ICPT's corporate and pre-commercial activities and the increase in personnel in support of these initiatives.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?